Axiom Investors LLC Natera, Inc. Transaction History

Axiom Investors LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$86.26 - $119.0 $2.73 Million - $3.77 Million	-31,685 Closed	0 $0
Q3 2021 Nov 12, 2021	SELL	$100.17 - $126.36 $3.84 Million - $4.84 Million	-38,315 Reduced 54.74%	31,685 $3.53 Million
Q2 2021 Aug 13, 2021	BUY	$86.05 - $119.72 $574,297 - $799,011	6,674 Added 10.54%	70,000 $7.95 Million
Q1 2021 May 14, 2021	SELL	$91.47 - $124.36 $2.5 Million - $3.4 Million	-27,354 Reduced 30.17%	63,326 $6.43 Million
Q4 2020 Feb 12, 2021	BUY	$66.66 - $111.74 $1.06 Million - $1.78 Million	15,944 Added 21.33%	90,680 $9.02 Million
Q3 2020 Nov 12, 2020	BUY	$45.89 - $72.67 $3.43 Million - $5.43 Million	74,736 New	74,736 $5.4 Million

526

119M

308K

191K

Ticker NTRA
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 96,957,400
Market Cap $14.2B
Description
Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify sing...

Get notified when there are updates to the investment portfolio of Axiom Investors LLC , based on Form 13F filings with the SEC.

Stay updated on Axiom Investors LLC with notifications on news.